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The new coronavirus infection will continue to pose a very severe challenge to the UK 
and to all countries around the world for the next 12 to 18 months.  An epidemic model 
has been developed to explore the range of possible actions open to the UK and other 
nations to combat the virus.  A "business as usual" policy would lead to the epidemic 
being over by September 2020, but such an approach would lead to a loss of life in the 
UK little less than that it suffered in the Second World War.  Using the J-value without 
constraint suggests that exceptionally high spending would be justified for the three 
strategies that could reduce significantly the numbers of cases and deaths compared with 
the unmitigated epidemic.  However such high spending is likely to come up against the 
J-value GDP constraint, whereby the measure should not so decrease GDP per head that 
the national population loses more life as a result of the countermeasure than it gains.  
The challenge for the UK Government (and other governments around the world) will be 
to manage its interventions so that the recession that is now inevitable is not significantly 
worse than that following the 2007 – 2009 financial crash. 
 





Coronaviruses come from a large family of RNA viruses that cause respiratory infections, 
ranging from the common cold to more serious diseases.  The Chinese authorities 
reported to the World Heath Organisation (WHO) on 31 December 2019 that they had 
discovered a disease caused by a coronavirus that had not been seen before in humans.  
The source of the virus is believed to have been a food market in Wuhan City, where 
many animals of different species were being kept together before being slaughtered for 
customers for food.  It is thought that the virus jumped species there.  The WHO has 
called the virus SARS-CoV-2, and named the illness it causes Covid-19 – coronavirus 
disease 2019. 
 
Paper for Nanotechnology Perceptions. 
Accepted Manuscript   
 
2 
The novelty of the virus in humans means that no immunity has built up against it.  In 
80% of cases, the disease is relatively mild, but the other sufferers may experience a 
more severe infection, particularly in those aged over 70 or with a pre-existing medical 
condition.  As of 22 March 2020, 335,511 cases had been reported worldwide, of 
whom14,611 had died; 97,636 were known to have recovered.  There were 5638 known 




Strong restrictions have been imposed on their citizens by many countries, including the 
UK, so as to reduce contact between people in an effort to lower the number of infections 
an infectious person passes on.  These measures have had the effect of dampening 
economic activity severely. 
 
This paper will use the Judgement- or J-value
2
 framework to explore the question of how 
much it is reasonable to spend on countermeasures.  To do this, it is necessary to estimate 
the beneficial consequences in terms of prolongation of life that the countermeasure 
brings about.  There is thus a requirement to model the dynamics of the spread of the 
epidemic based on available data.  
 





“The essential value of models is that operations on the models enable conclusions 
to be drawn about the behaviour of the system represented.” 
 




“the following maxim holds for all sciences: Never aim for more precision than is 
required for the problem in hand.” 
 
and it may be concluded that simplicity should be a major aim for a useful model.  A 
straight-forward model is particularly appropriate when, as now, there are limitations on 
the data on which to build a more complex version. Thus a simple mathematical 
description will be derived for the Covid-19 epidemic.  The model is based on an 
adaptation of a point model of the dynamics of a nuclear reactor
5
, which has structural 
similarities in the mathematics.  Algebraic rearrangement of the final model shows that 
the coupled differential equations produced are equivalent to the SIR model (Susceptible-
                                                 
1 Worldometer, COVID-19 Coronavirus Pandemic, updated March 22, 2020, 
https://www.worldometers.info/coronavirus/  
2 Thomas, P. J., Stupples, D. W. and Alghaffar, M. A., 2006, "The extent of regulatory consensus on health 
and safety expenditure.  Part 1: Development of the J-value technique and evaluation of regulators' 
recommendations", Process Safety and Environmental Protection, 84(B5): 329 – 336, September. 
3 Finkelstein, L., 2006, “From technology to wider knowledge, understanding and wisdom”, Special 
Feature on Systems and Risk, Measurement + Control, Vol. 39/ 9, 268 – 272, November. 
4 Popper, K. R., 1983, Realism and the aim of science, Hutchinson, London.  Preface 1956. 
5 Thomas, Philip, 1999, Simulation of industrial processes for control engineers,  Butterworth-Heinemann, 
Oxford, UK.  Chapter 21,  Nuclear Reactors. 
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 often used in epidemiological studies.  The model's predictions will 
be compared against recorded data to this point in time and against those of the Imperial 
College model, which have been reported to Government. 
 
The layout of the paper is as follows.  Section 2 will explain the J-value and use it to 
derive the worth of a year of life to an average UK citizen.  The Section will go on to 
introduce a constraint for the case where the permissible level of spending is so great that 
it will adversely affect the nation's Gross Domestic Product. 
 
Section 3 will present the data available to populate the epidemic model.  The model 
makes the assumption that a person who has recovered from the disease will then be 
immune to it (there have been a few cases reported from Wuhan of people falling ill a 
second time but these probably occurred when a false negative occurred on their viral 
test.
7
)  A comparison will then be made between the model's predicted cumulative totals 
of infected people in the UK and the observed figure from 31 January to 22 March 2020.  
Section 4 will compare the model outputs with the results of the Imperial College 
epidemic model. 
 
Section 5 will discuss the 5 basic strategies available to the UK (and other developed 
countries) at this time, ranging from "business as usual" (Option 0) to a lockdown of 12 
months in the hope of developing a vaccine and immunising a substantial fraction of the 
UK population before the restrictions are lifted (Option 5).  The benefits of the four 
active policy options will be established in terms of the reduction in life years lost 
compared with Option 0. 
 
Section 6.1 will apply the J-value in a straightforward way to evaluate the justifiable cost 
for each countermeasure.  Section 6.2 will derive the numerical value of the maximum 
reduction in GDP permissible before the countermeasure causes greater loss of life than it 
averts.  The difficult economic challenge facing the UK Government will be presented in 
numerical terms. 
 
Section 7 will discuss how far uncertainties in the data are likely to affect the main 
findings. 
 
Section 8 presents the conclusions. 
 
Appendix A derives the dynamic model of epidemic spread in an intuitively appealing 
way.  The appendix includes a derivation of the fraction that will give "herd immunity" to 
the population as a whole.  This epidemiological term is used to denote the smallest 
fraction of people (or animals, depending on context) who need to have gained immunity 
                                                 
6 Kermack, W. O. and McKendrick, A. G., 1927, "A Contribution to the Mathematical Theory of 
Epidemics." Proc. Roy. Soc. Lond. A 115, 700-721. 
7 Zuo, M., 2020, "Coronavirus: why do ‘recovered’ patients test positive again?", South China Morning 
Post, 4 March.  https://www.scmp.com/news/china/society/article/3065022/coronavirus-why-do-recovered-
patients-test-positive-again  
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for an infection introduced into the population to be deprived of sufficient hosts to be 
sustained.  The infection will then decline. 
 
Appendix B shows how the cumulative total of cases predicted by the model may be 
converted into loss of life expectancy, taking into account the variation in fatality rate 
with age.  Appendix C explains how the value of a life year may be found using the J-
value. 
 
2.0 The J-value 
 
2.1  The worth of a year of life in the UK 
 
The Judgment- or J-value allows an objective and validated assessment to be made of the 
maximum that ought to be spent on a measure to extend life expectancy.  It is based on 
the life quality index, Q, devised by Nathwani, Lind and Pandey
8
 following a project 
discussion with Ernest Siddall
9
, which may be written: 
 
1Q G X   (1) 
 
where G is the average income, taken for ethical reasons to be the annual Gross Domestic 
Product (GDP) per person, X is the population-average life expectancy and   is risk-
aversion (or the negative of the elasticity of marginal utility of income).  The same 





Perturbing equation (1) yields: 
 
 1Q G X
Q G X
  
     (2) 
 
where X  is the average change in life expectancy across the population.  The 
requirement that the safety measure should not produce a net disbenefit is that 0Q  , 
with the limiting case occurring at 0Q  .  Applying this condition to equation (2) gives 
the maximum it is worth paying per person protected per year to achieve a gain in 











  (3) 
                                                 
8 Nathwani, J.S., Lind, N.C., Pandey, M.D., 1997. Affordable Safety by Choice: the Life Quality Method, 
Institute for Risk Research, University of Waterloo, Waterloo, Ontario, Canada. 
9 Lind, N. and Nathwani, J., 2012, "Origin and development of the LQI", LQI Symposium in Kgs. Lyngby, 
Denmark August 21-23, 
10 Thomas, P. J., Stupples, D. W. and Alghaffar, M. A., 2006, "The extent of regulatory consensus on 
health and safety expenditure.  Part 1: Development of the J-value technique and evaluation of regulators' 
recommendations"  Process Safety and Environmental Protection, 84(B5): 329 – 336 
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where the negative sign preceding G  indicates a reduction in effective annual income.   
 
The J-value is then the ratio of the actual cost per year, Ĝ , to the maximum reasonable 







    (4) 
 
Hence the J-value may be written: 
 






   (5) 
 
1J   implies that the safety measure is, in the absence of special pleading to the 
contrary, too expensive.   
 
At 1J  , the amount per year actually being spent, Ĝ , will be equal to the maximum 












  (6) 
 
By assuming that all life-extending decisions are governed by a J-value of 1.0, Thomas 
and Waddington were able to validate this expression in 2017 as a descriptive model of 
the assessment process applied all over the world 
11
.  Very good correspondence between 
actual and predicted population-average life expectancy against GDP per head (a 
correlation coefficient, R, of 0.77) was found for 180 out of the 193 nations recognised 
by the United Nations in 2009 and excellent correspondence (R = 0.89) for 162 countries.  
In addition, the J-value provides the first causal explanation of the Preston curve of life 





















  (C.3) 
 
where 1X  is the population-average life expectancy for the current generation and the 
bracketed superscript in 
 1
V  emphasises that this is for a single citizen. 
                                                 
11 Thomas, P. and Waddington, I., 2017, "Validating the J-value safety assessment tool against pan-national 
data", Process Safety and Environmental Protection, Vol. 112A, 179 – 197, November. 
12 Preston, S.H., 1975. The changing relation between mortality and level of economic development. 
Population Studies, Vol. 29 (2), 231–248 
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The value of risk-aversion for developed countries is found to be 0.91  , while the 
social discount rate, *r , should be taken
11
 as the rate of growth of GDP per head, found 
to be  2.03% per annum for the UK for the period 1961 to 2013.
13
  The UK GDP per 
head
14
 in 2019 is G = £33,141, while, from the latest ONS life tables (for 2016 – 2018), 
1 41.8X  . years.
15
  Inserting these figures into equation (C.3) gives the best current 
estimate of the value of a life year in the UK as: 
 
 1 248£ ,209V    (7) 
 
This implies that the Government and commercial organisations in the UK would be 
justified in spending up to just under a quarter of a million pounds on a scheme that 




This approach implies the following steps.  First, an estimate may be made using the 
model of the number of people dying at each age.  This allows a calculation to be made 
of how many years of life expectancy will be lost to Covid-19 at each age and the total 
expected loss of life years may be found.   
 
Next, using the same process, the total number of life years may be found that would be 
lost after implementation the countermeasure.  The reduction in life years lost (or, 
equivalently, the restoration of life years) is then multiplied by the value of a year of life 
given by equation (7) and the result is the maximum expenditure that should be 
contemplated for that measure. 
 
2.2  J-value GDP constraint for exceptionally large justifiable costs 
 
                                                 
13 World Bank, 2017, "World Development Indicators: GDP per capita growth (annual %)", updated 1 
February. Available at: http://data.worldbank.org/indicator/NY.GDP.PCAP.KD.ZG . 
14 Office of National Statistics, 2020, Gross domestic product (Average) per head, at current market prices: 
SA, https://www.ons.gov.uk/economy/grossdomesticproductgdp/timeseries/ihxt/pn2   
15 Office of National Statistics, 2020, National life tables, UK: 2016 to 2018, 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulleti
ns/nationallifetablesunitedkingdom/2016to2018  
16 The figure given in equation (7) differs markedly from the value assigned to the "quality-adjusted life 
year", QALY, used by the National Institute for Health and Care Excellence (NICE), which advises the 
National Health Service on whether a drug is to be regarded as cost-effective or not.  NICE estimates that a 
year in full health is worth between £20,000 and £30,000*, figures that have not increased since the 
Institute was set up in 1999.  They bracket symmetrically the value of a life year, £25,000, that could be 
found by dividing the life expectancy of the average UK citizen of 1997 (~40 years) into the "value of a 
prevented fatality" (VPF), £1.0M, used by the Department for Transport (DfT) at that time.  But it has been 
shown that the method used to find the VPF was invalid and that the monetary value assigned to the VPF is 
plain wrong and far too low.  NICE's value of the QALY is an even greater understatement since it takes 
account of neither inflation nor the growth of the economy in the last 23 years.  *Sir Andrew Dillon, 2015, 
"Carrying NICE over the threshold", https://www.nice.org.uk/news/blog/carrying-nice-over-the-threshold ; 
Thomas, P. and Waddington, I., 2017, "What is the value of life? A review of the value of a prevented 
fatality used by regulators and others in the UK", Nuclear Future, Vol 13, No. 1, pages 32 – 39.  Available 
at: http://www.bristol.ac.uk/cabot/news/2017/research-review-safety.html   
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7 
The derivation above of the value of a year of life rests on the normal economic 
assumption that the system is perturbed about its operating point and not moved to an 
entirely new region of operation.  However, protection schemes should not be put in 
place if their costs are large enough to cause the nation's economic output to fall so 
significantly that it will cause more loss of life than if the scheme had never been 
implemented.   
 
In such circumstances a J-value GDP constraint needs to be applied, based on the cause-
and-effect relationship found by Thomas and Waddington in their validation of the J-
value against pan-national data.
11
  As noted previously, that paper provides the first 
quantified causal explanation of the fact that we get to live longer as we grow richer in 
the way shown in the Preston curve.
11
  Additional work examining detailed statistics for 
the UK and for 35 industrialised countries has further corroborated the J-value 





In particular, the J-value approach reveals the following causal relationship between GDP 










   (8) 
 
where 0X  is the population life expectancy and 0G  is the GDP per head before the 
countermeasure is implemented.  The situation may be clarified by expressing the fall in 
population-average life expectancy as 0X X X    and the fall in GDP per head as 





X X G G
X G

   
  
 
   (9) 
 
If the countermeasure causes a fall in GDP per head, withG , so large that the drop in 
population-average life expectancy with the measure, withX , exceeds the reduction in 
life expectancy without, withoutX : 
 
with withoutX X      (10) 
 
then the measure should not be adopted and other methods of mitigation should be 
sought. 
 
                                                 
17 Thomas, P., 2017, "Corroboration of the J-value model for life-expectancy growth in industrialised 
countries", Nanotechnology Perceptions, Vol. 13, 31 – 44.  Available at: 
http://www.jvalue.co.uk/papers/2017-CorroborationOfJvalue.pdf  
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8 
Condition (10) provides a J-value-based constraint to the results coming from applying 
the J-value in the normal way, as outlined in Section 2.1. 
 
3.  Data for the epidemic model 
 
The number of people that will be infected in a susceptible population by the average 
Covid-19 sufferer, the basic reproduction number, 0R , was taken to be 2.35 based on 
Wuhan data.
18
  The incubation period, inc , was taken to be 5 days based on the same 
study while the period of infectiousness was taken to be 10 days.
19
   
 
The standard assumption is that a just-infected person will undergo an incubation period, 
inc , and will then be liable to infect others for a risk period, risk .  It is possible, however, 
that the person may be infectious in the later stages of the incubation period.  Allowing 
for this, a general statement of the average time, inf , to infect others, measured from the 
time the first person is infected, may be written as equation (A.1) of Appendix A:  
 










   (A.1) 
 
When the person is not infectious during the incubation period, 1 1.0r   and when 
the infectiousness is uniformly distributed over the normal risk period, 2 0.5r  .  These 
values for 1r  and 2r  were taken as the starting assumption, but after matching model 
predictions to recorded cases as of March 19, the coefficient, 1r , was reduced slightly to 
0.9, implying that infectiousness begins 12 hours before symptoms show.  Hence the 
average time, inf , to infect others, from the moment of infection was taken to be 0.9 x 5 
+ 0.5 x 10 = 9.5 days. 
 
Based on ONS figures, the UK population is taken to be 67 million. 
 
Two people tested positive with the corona virus, SARS-CoV-2, in the UK at the end of 
January.  Initialising the model with this number allows a comparison to be made with 
the recorded figures.  Figure 1 shows the trend in recorded cases to 22 March 2020 to be 
captured reasonably accurately. 
 
It is fortunate that little effect has been observed on children and young people from the 
disease.  Moreover, in 80% of cases the symptoms are mild and the sufferer recovers 
after a week or so.  However the incidence of serious effects rises with age, particularly 
                                                 
18 Kucharski, A. J., Russell, T.W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., Eggo, R. M., 2020, "Early 
dynamics of transmission and control of Covid-19: a mathematical modelling study", The Lancet, March, 
https://doi.org/10.1016/S1473-3099(20)30144-4  
19 Anderson, R. M., Heesterbeek, H., Klinkenberg, D. and Hollingsworth, T. D., 2020, "How will country-
based mitigation measures influence the course of the Covid-19 epidemic?", The Lancet, March, 
https://doi.org/10.1016/S0140-6736(2)30567-5  
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9 
after the age of 70, when fatality rates begin to rise more sharply.  Imperial College's 
Covid-19 Response Team suggest that the rate of death against age in the UK would 
follow Table 1
20
.  These rates, which are based on an analysis of data from Wuhan, 
China, assume that normal UK hospital capability is not overwhelmed, an important 
condition given the large numbers of cases that might occur.   
 
The availability of ventilators and intensive care units in the UK is known be insufficient 
to deal with hundreds of thousands of cases.  Therefore a number of scenarios are 
considered where the more severe incidence of fatality reported in Wuhan
21
 applies.  The 
Wuhan fatality rates are given in Table 2. 
 
4.0  Comparison of the model given in this paper with that of Imperial College 
 
The Imperial College simulation for the "do nothing" or "business as usual" case assumed 
that the UK hospitals could cope with the numbers of coronavirus sufferers referred to 
them and so used the fatality rates of Table 1. 
 
Using the same figures in this model produces Figure 2, which shows the course of the 
epidemic in the absence of countermeasures in terms of the number of people suffering 
from Covid-19 as a function of time.  The number of people suffering from the virus a 
any one time starts to rise very rapidly in the second half of April and reaches a peak of 
14.2 million, just over 20% of the UK population, on 3 June.  The number of people who 
have been infected at this point will be 38.5 million, which represents about 57.5% of the 
total population (in line with equation (A.16)).  The number of sufferers will start to 
reduce from this point onwards, and the epidemic will be nearly over by the end of 
August.  By this time, however, 58.4 million people will have been infected in total, 
which represents 87% of the population.   
 
The total number of deaths is calculated as 573,000, which implies an overall death rate 
of 0.99%.  The amount of life expectancy lost is 8.4 million years, and, on average, each 
victim loses 14.6 years of life. 
 
For comparison, Ferguson et al.
18
, who set their basic reproduction number, oR , to 2.4 
rather than the slightly lower figure of 2.35 used in this study, quote a cumulative total 
number of infections at the end of the epidemic of 81% of the UK population, which 
implies 54.3 million people.  They do not quote predicted numbers of people suffering 
from the virus each day, but their Figure 1 shows deaths peaking at around the middle of 
June, suggesting that the peak of such infectious cases would have occurred around the 
end of May in their model (cf. 3 June in this paper's model). 
 
                                                 
20 Ferguson, N. M. et al, 2020, "Impact of non-pharmaceutical interventions (NPIs) to reduce Covid-19 
mortality and healthcare demand", Imperial College, 16 March https://www.imperial.ac.uk/media/imperial-
college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf  
21 Worldometers, "Age, Sex, Existing Conditions of Covid-19 Cases and Deaths", 
https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/  
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Their model suggests 510,000 deaths, which implies a death rate of 0.94%.   These two 
figures are similar to those produced by this paper's model.  If the Imperial College 
figures for percentage of infections and death rate were regarded as more accurate, then 
applying a correction factor of 0.094 0.099 81/ 87  to this paper's total gives 509,000 
deaths, essentially the same result.   
 
Within the accuracy of the data, it may be concluded that the two models are predicting 
pretty much the same scenario.  The dates quoted should be regarded as indicative only – 
the aim and benefit of this model is to capture the main modes of the epidemic. 
 
5.0  Possible strategies to counter the Covid-19 epidemic 
 
There will be additional, indirect premature deaths when hospitals are overloaded due to 
medical staff being unable to provide all patients with the care they need.  This would 
add to the figures for premature death for Options 0, 1 and 2.  However, given the 
relatively short period predicted for extreme stress on the hospitals, the already very high 
figures would not be expected to rise significantly. 
 
5.1  Option 0: "Business as usual", where hospitals are overwhelmed; Wuhan 
fatality rates of Table 2 are applied  
 
Figure 2 gives the number of infectious people as a function of time.  Like other 
countries, the UK does not have the hospital capacity currently to cope with the numbers 
of people who would need hospitalisation. Hence Table 2 is used to represent the fatality 
rates for this Option 0 as this table is likely to represent better the situation where the 
UK's hospitals are overwhelmed by a high number of severe cases of Covid-19.   
 
The trend of the epidemic shown in Figure 2 is unaltered, but the overall death rate now 
goes up to 1.7%.  The resultant number of deaths rises in proportion to 990,000.  16.7 
million years of life are expected to be lost.  This implies the average victim loses just 
under 17 years of life expectancy, significantly below the life expectancy, 42 years, that 
would have been lost if all age groups had been equally at risk. 
 
The prime minister, Boris Johnson, has likened the struggle against Covid-19 to a war.  
Continuing with that comparison, the UK sustained 880,000 military casualties and 2,000 
civilian deaths
22
 in World War I.  Since the soldiers, sailors and airmen killed would have 
been predominantly young, a reasonable estimate of the total loss of life expectancy 
incurred is approximately 44 million life years.   
 
We may put this very large figure on a scale that is easier to understand by dividing it by 
the life expectancy from this point on for the average UK citizen in 2020, a unit we may 
name the population-average life expectancy or plex.  We may take the plex for 2020 as 
                                                 
22 www.parliament.uk, The fallen. Military strength and deaths in combat, Excerpt from Thompson, G. et 
al., 2012, Olympic Britain Social and economic change since the 1908 and 1948 London Games, House of 
Commons Library, London. 
https://www.parliament.uk/business/publications/research/olympic-britain/crime-and-defence/the-fallen/  
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42 years in round figures (for comparison, life expectancy is 81 years at birth, 41 years 
for a forty-year-old, 9 years for an eighty-year-old).  It is the amount of life a person 
selected at random from the population would, on average, lose if he or she were 
unfortunate enough to be killed tomorrow.  On this basis the loss of life in WWI is 
equivalent to 1.05 million average UK citizens losing their lives today or 1,050,000 plex-
2020.   
 
Meanwhile 384,000 UK military personnel were lost in World War II, while 70,000 in 
the civil population lost their lives.  This implies a loss of approximately 22 million years 
of life expectancy, which translates into 525,000 plex-2020, as shown in Table 3. 
 
The loss of life under Option 0 will be just under 400,000 plex-2020, about four fifths of 
that lost in WWII and 40% of the losses in WWI.  This scale of potential loss amply 
justifies Boris Johnson's analogy.  One difference from those wars, however, is that 
although the eventual level of human loss of life to Covid-19 is not known with great 
precision in advance (what is available is only a model prediction), the attainment of herd 
immunity more or less guarantees eventual victory in the battle against the virus.  
 
5.2  Option 1: 4 month lockdown followed by a lifting of restrictions; start time 
chosen to minimise deaths and give the UK herd immunity from further Covid-19 
epidemics; Wuhan fatality rates (Table 2) 
 
In the absence of improved medical care (thousands more ventilators, improved 
therapies) to reduce fatality rates or of a new vaccine to give herd immunity without 
people contracting the infection, one method of reducing fatalities is to reduce the basic 
reproduction number, 0R , by lockdown for a period of time at an optimally chosen start 
date and then to remove the restrictions.  Wuhan Province managed to reduce the average 
number of transmissions from an infectious person to 1.05 within about a week.
17
   
 
Setting the period of lockdown at 120 days, it is found using the model that the optimal 
policy is to institute a step reduction in 0R  on 25 May, from a starting value of 2.35 down 
to 1.05.  The latter figure is exactly that observed at Wuhan after lockdown.  The step 
change is made 9 days before the peak observed in Option 0.  Figure 3 shows the 
transient of infectious people, which now reaches a maximum that is about 3 million 
lower than under Option 0.  Hospital facilities can, however, still be expected to be 
overwhelmed and so the Wuhan fatality rates of Table 2 have been used for this Option.   
 
The peak number of deaths will be reduced to 656,000, with an associated loss of 11.1 
million years of life.  Under the strategy outlined above, the cumulative total of people 
infected will be 38.7 million, just over the number, 38.5 million, required to give herd 
immunity.  This means that no second significant outbreak would occur. 
 
Option 1 restores about a third of the life expectancy lost in Option 0, around 5,620,000 
years or 134,000 plex-2020. 
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12 
Getting the timing right is, however, critical, as implementing the lockdown too early or 
too late produces strongly suboptimal results.  A month too early or a month too late and 
the result is only slightly better than business as usual.  A reasonable window for action, 
when most of the benefit may be gained, is essentially no more than 5 days either side of 
the optimal figure. 
 
5.3  Option 2: early 12 month lockdown followed by a lifting of restrictions; Wuhan 
fatality rates (Table 2) 
 
For a lockdown period of 12 months starting 31 March 2020, the number of infections a 
year later will be kept down to about 1.1 million.  The number of deaths may be 
estimated using the non-overwhelmed overall fatality rate of just below 1 % and is 
therefore about 11,000 by the end of March 2021.  However, this is not the end of the 
story as, unfortunately, lifting the restrictions after a year will allow the disease, not 
totally eradicated at this point, to re-establish.  The result will be an epidemic that is little 
different from what would have occurred a year earlier.  See Figure 4, which depicts an 
epidemic that is in all essentials a delayed version of that shown in Figure 2. 
 
Without measures having been taken to increase hospital capacity in the interim, 
hospitals will be overwhelmed and the Wuhan fatality rates of Table 2 are now 
appropriate.  A relatively small number of premature deaths, 4,500, are still avoided and 
the corresponding number of years of life expectancy restored is 76,500 or 1,800 plex-
2020.   
 
5.4  Option 3: early 12 month lockdown followed by a second, optimally timed 4 
month lockdown later; greatly enhanced hospital capacity made available by the 
end of 12 months; Table 1 fatality rates 
 
The initial lockdown is for 1 year, starting 31 March 2020.  The epidemic starts up again 
as shown in Figure 4, but now there is a second lockdown lasting 120 days, starting 15 
May 2021.  See Figure 5.  The effect of the second lockdown is to reduce the final total 
number of infections from 58.4 million under Option 0 to 38.4 million under Option 3, 
approximately the level needed to induce herd immunity. 
 
The enhanced capacity assumed for the hospitals means that they are not now overloaded 
and so the death rates of Table 1 may be used.  There are now 368,000 premature deaths, 
and the total loss of life expectancy is 5.4 million years.  This represents a saving of 11.3 
million expected years or 270,000 plex-2020 compared with Option 0.   
 
5.5  Option 4: early 12 month lockdown with widespread vaccination at the end of 
the lockdown period using a newly developed vaccine; Table 1 fatality rates  
 
It is assumed under Option 4 that 38.5 million people will have been vaccinated by the 
end of the year-long lockdown, a sufficient number on its own to give herd immunity.  
This is simulated by adding 38.5 million to the model's number of recovered and infected 
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13 
people on 31 March 2021.  The resultant transient in infectious people is shown in Figure 
6. 
 
The final total number of people to have been infected will be 1.3 million.  Given that 
hospitals should not be overwhelmed, the fatality rates listed in Table 1 are appropriate, 
implying a total of about 13,000 premature deaths.  This is less than the average annual 
number, 17,000, of influenza deaths in England over the past 5 years.
23
   
 
Each Covid-19 victim would lose, on average, 14.6 years of life.  Hence the total loss of 
life expectancy is 189,000 years or 4,500 plex-2020. 
 
Compared with Option 0, Option 4 would avoid 977,000 premature deaths and restore 
16.5 million life years or 393,000 plex-2020.   
   
6.0 J-value analysis of the options 
 
6.1  J-value analysis based on valuation of life years, as described in Section 2.1 
 
Table 4 summarises the characteristics of the 5 possible options at the UK's disposal to 
combat Covid-19.  
  
Option 1, an optimally timed 4 month lockdown, would reduce the loss of life from 
400,000 to 260,000 plex-2020, a substantial saving.  Applying the J-value at the 
recommended point of J = 1 gives the maximum that should be spent on the 4 month, 
optimally timed lockdown as £1,395 billion.  Clearly massive spending is justified in 
principle for this option.  However, this constitutes about two thirds of the UK's Gross 
Domestic Product of £ 2,215 bn in 2019.
24
    
 
In practice it would be difficult to get the timing right and a saving of 100,000 plex-2020 
might be more realistic.  Nevertheless such an outcome would still justify the spending of 
a trillion pounds under the J-value 
 
Option 2, a lockdown of 12 months followed by a return of the epidemic on a similar 
scale to Option 0, would make little difference.  It would be worth spending only £19bn 
on the benefit it would produce, and it is clear that such a sum would not begin to cover 
the economic cost of a year's lockdown for the nation. 
 
Option 3, a year's lockdown, allowing time for sufficient supplies of both ventilators and 
intensive care beds to be built up, followed by an optimally timed 4 month lockdown 
would reduce the loss of life to 130,000 plex-2020.  This would reduce the threat to about 
a third of that under Option 0.  Applying the J-value criterion at J = 1, the justifiable cost 
                                                 
23 Public Health England, 2019, Surveillance of influenza and other respiratory viruses in the UK Winter 
2018 to 2019, https://www.gov.uk/government/statistics/annual-flu-reports  
24 ONS, 2020, GDP first quarterly estimate time series, Sheet A2, GDP and GVA in £ million, 
https://www.ons.gov.uk/economy/grossdomesticproductgdp/datasets/secondestimateofgdp  
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of enabling this scenario to happen is £2820 bn.  This enormous sum is, however, greater 
than the country's GDP in 2019. 
 
In Option 4, 38.5 million people are vaccinated in the closing stages of a 12 month 
lockdown.  This strategy would be highly successful in combating the virus, with a loss 
of less than 5000 plex-2020.  The J-value analysis of Section 2.1 suggests that the 
justifiable cost of such a set of countermeasures (a year's lockdown, development of an 
effective vaccine and widespread immunisation within a timescale of about 12 months) 
would be £4095 bn.  However, this sum falls not far short of twice the UK's GDP in 
2019. 
 
Clearly Option 2 is a non-starter.  Options 1, 3 and 4 would each save a lot of human life.  
Option 3 relies mainly on technology that has been developed already and the challenge 
would be to get enough equipment manufactured in time, enough temporary hospitals 
built and sufficient trained staff to operate them.  An additional bonus, not accounted for 
in the figures presented, would come from the repurposing of existing anti-viral therapies 
to attack the coronavirus, which would improve upon the survival rates of Table 1. 
 
Option 4 is obviously highly attractive from the point of view of rendering the 
coronavirus less harmful in practice than an average year of influenza.  There is also 
encouraging news on vaccine development, with a US vaccine being tested on humans in 
mid March 2020 and a UK vaccine being applied to animals at the end of March 2020 




Very great expenditure on each one of Options 1, 3 and 4 is justified under the J-value 
method outlined in Section 2.1.  However, it is necessary to consider the J-value GDP 
constraint when the justifiable amounts are comparable with a full year's GDP.   This 
consideration is the subject of the next subsection 
 
6.2  The effect of the J-value GDP constraint for exceptionally large justifiable costs 
 
The UK Government (along with many other governments in the developed world) 
appears to be pursuing a mixture of Options 3 and 4: Option 4 ideally, but with some 
version of Option 3 as a fall-back position if no vaccine becomes available in time.  It is 
also plain from the measures that have been announced by the UK Government that it 
intends to spend very large sums of money.
26
  However, it is also clear that the 
Government's lockdown will cause cutbacks to GDP.  For example, as of 19 March 2020, 
the hospitality (pubs, restaurant, cafes) and leisure (cinemas, clubs, theatres) industries 
have been instructed to suspend activities indefinitely and the same applies to sports and 
leisure. 
 
The most effective countermeasure in terms of reducing life lost is Option 4, which 
restores 16.5 million years of life/ 393,000 plex-2020 that would otherwise have been 
                                                 
25 Whipple, T., 2020, "Vaccine trials start at Porton Down in race to find a cure", The Times, 21 March 
26 Swinford, S., 2020, "Coronavirus: Chancellor Rishi Sunak announces 'enormous' wage bailout", The 
Times, 21 March. 
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lost.  However, if the cost borne by UK citizens of implementing Option 4 is so great that 
their total life expectancy is reduced by an even greater amount, then the option should 
not be pursued.  This condition may be written: 
 
16,500,000N X    (11) 
 
where N is the number in the UK population, viz. 67,000,000.  Solving for X  gives a 
permissible decrease in population-average life expectancy of 0.25 years.  This translates 









   
 
   (12) 
 







   (13) 
 
This implies that a recession resulting in a general fall in economic output of 6.4% per 
person over a prolonged period would cost more life than would be restored by Option 4.   
 
The theory behind the calculation assumes quasi-steady conditions and it is not expected 
that a temporary fall of 6.4% followed by an immediate recovery would lead to this drop.  
However a prolonged recession of this magnitude would be expected to have such an 
effect. 
 
For comparison, in the economic recession of 2007 – 2009, the real-terms GDP per head 
fell by 6% between 2007 and 2009 (see Figure 7), and did not recover to its 2007 figure 
until 2015.  The effect of the recession on life expectancy is seen in Figure 8, where the 
life expectancy at age 42 is displayed as an approximate proxy for population-average 
life expectancy.  The effect of the reduction in GDP per head appears about 3 years after 
the severe dip of 2008 – 2009 occurs, when the clear upward trends for both men and 
women are markedly reduced.  Flat-lining is apparent after 2014.  Moreover, a fall in life 
expectancy at birth is observed in  the case of females born to the most deprived 10% of 
the population.
27
   
 
While J-value analysis would predict some degree of concavity for the graphs shown in 
Figure 8, nevertheless it is clear that life expectancies at age 42 would have been at least 
3 months greater by 2017 than those shown in Figure 8 in the absence of the recession 
followed by only a slow recovery. 
 
                                                 
27 Marshall, L. et al., 2019, Mortality and life expectancy trends in the UK: stalling progress, The Health 
Foundation. 
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The Centre for Economics and Business Research is now predicting that the coronavirus 
pandemic will cause global GDP to decline twice as much as during the financial crisis of 
2007 – 2009.  Furthermore, it raises the prospect of a 1930s-style recession.
28
  Such an 
outcome, if it were to come about, would cause a loss of life years to the UK population 
that would dwarf the predicted toll under Option 0. 
 
Based on a sector by sector analysis of the effects of lockdown on the German economy, 
the IFO Institute of Munich has recently concluded that a partial shutdown of 2 months 
duration will reduce German annual GDP by between 7.2 and 11.2 percentage points, 
while extending the period by a further month would cause annual GDP to fall by 
between 10 and 20.6%.
29
  Such outomes, if they were transferred to the UK, would be 
sufficient to cause significantly greater loss of life than would be gained by the lockdown 
measure, especially if the partial shutdown of the economy were to last more than 2 
months in total. 
 
Thus the Government faces health and economic challenges of equal severity.  It needs to 
institute reasonable countermeasures against Covid-19 but it needs, at the same time, to 
attempt to restrict the coming recession to not much worse than the 2007 – 2009 financial 
crash. 
 
7.  Uncertainties in the modelling of the epidemic and its effects 
 
Information on the coronavirus epidemics around the world is growing and there will be 
scope for refinement of the figures presented here, especially if, as looks likely, time is 
bought through governments adopting variants of either Option 3 or Option 4.  The exact 
size of the outbreak and all the dates quoted from the model should be regarded as 
indicative only.  However the main modes of the epidemic's behaviour and the orders of 
magnitude of the numbers of people affected under the various options are regarded as 
good enough to guide policy decisions. 
 
8.0  Conclusions 
 
There is no doubt that the new coronavirus infection is posing and will continue to pose a 
severe challenge to the UK and to all countries around the world.   
 
Less developed countries do not have such good public health systems, but on their side 
is the fact that their populations contain high proportions of young people who have been 
observed to be much less vulnerable to severe effects.  By contrast, the developed 
countries have better health systems, but on the other hand they have much higher 
percentages of older people who are more likely to be badly affected. 
                                                 
28 Centre for Economics and Business Research, 22 March 2020, https://cebr.com/reports/a-world-
recession-is-now-almost-a-certainty-with-global-gdp-set-to-decline-twice-as-much-as-during-the-financial-
crisis-the-challenge-now-is-to-prevent-the-recession-from-turning-into-a-1930s-style/  
29 Dorn, F. et al., 2020, "The economic costs of the coronavirus shutdown for Germany: a scenario 
calculation", IFO Institute, EconPol Policy Brief 21 2020, Vol. 3, March (completed 22 March). 
https://www.econpol.eu/publications/policy_brief_21  
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The range of possible options has been explored using the epidemic model developed in 
the paper.  A "business as usual" approach would lead to the epidemic being over by 
September 2020, but it would lead to a loss of life comparable to that suffered by the UK 
in the Second World War.  An optimally timed 4 month shutdown starting a little time 
before the peak would otherwise have been reached could cut casualties by a third and, 
again the epidemic would be all but over by September 2020.  However this option would 
still leave a high residual number of fatalities caused by the virus. 
 
A 12-month lockdown on its own would merely delay the onset of the epidemic by a year 
and the number of deaths would be little altered from the business as usual approach.   
This strategy (Option 2 of the paper) should not be followed. 
 
However, a 12 month lockdown during which fully-equipped hospital capacity was 
prepared, followed by an optimally timed 4 month shutdown could cut casualties by two 
thirds. 
 
A 12 month lockdown during which a vaccine was developed and a large-scale 
immunisation programme was carried out would cut the damage done by the coronavirus 
to less than the average toll on people caused by influenza each year. 
 
Using the J-value without constraint suggests that exceptionally high spending would be 
justified for the three strategies able to make a significant reduction in the numbers of 
cases and deaths compared with the unmitigated epidemic.  However such high spending 
is likely to come up against the J-value GDP constraint, whereby the measure should not 
decrease GDP per head so much that the UK population as a whole loses more life than it 
gains from the countermeasure. 
 
The challenge for the UK Government will be to manage its interventions so that the 
inevitable impending recession is not significantly worse than the 2007 – 2009 financial 
crash.  The pandemic nature of the problem means that all governments around the world 
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Appendix A. Model of the Covid-19 epidemic in the UK 
 
Let the number of people in the national population be N and let the number of people 
who are infectious with the corona virus, SARS-CoV-2, be n .  
 
A just-infected person will undergo an incubation period, inc  (about 5 days), and will 
then be liable to infect others for a risk period, risk  (about 10 days).  It is possible, 
however, that the person may be infectious in the later stages of the incubation period.  
Allowing for this, a general statement of the average time, inf , to infect others, measured 
from the time the first person is infected, may be written:  
 










   (A.1) 
 
When the person is not infectious during the incubation period, 1 1.0r   and when 
the infectiousness is uniformly distributed over the normal risk period, 2 0.5r  . 
 
It will now be assumed that all the transfer of virus will occur by a single contact inf  
days after the person was infected.  The number of people infected by the average person 
will be the basic reproduction number, 0R .    By this model, inf  marks the beginning and 
end of the onward transmission of infection for the person passing on the virus.  
Thereafter he or she will either recover or, in a small fraction of cases, become ill and die.  
Clearly the instant of transmission also marks the start of the infection for the individual 
receiving it.  Hence inf  may be regarded as the average time between generations of 
infected people.   
 
Infections will be passed continually from one person to another, and we will cater for 
this by assuming that at any instant the periods since infection amongst those with the 
possibility to infect will have a uniform distribution between 0 and inf  days.  Let us 






    (A.2) 
 
Let us also divide the n  people with the potential to infect others, whom we may regard 
as the current generation of infected people, into M groups, each of which contains nG  





G    (A.3) 
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Making M very large implies t  0 from equation (A.2), and this allows us to consider 
that all the people in each group were infected at the same time.  Although this will only 
be an approximation early on,  there will no problem in practice in regarding M as very 
large fairly soon for an epidemic predicted to reach many millions of people.     
 
Let us assign the name Group 1 to the group in the current generation that contains the 
people who were infected first and are about to pass on their infection.  Group 2 will 
contain those with the second oldest infections, and so will pass the disease on next.  We 
may then continue this process of assignment until we encounter the last group of the 
current generation to have been infected, which will be given the name Group M.   
 
Figure 9 shows how the M groups of the current generation pass on their virus load to the 
next generation.  The figure illustrates an important fact about an epidemic, namely that 
the number of people to whom the average infected person will pass on an infection will 
fall over time as the people in the contact group are increasingly likely either to be 
infected already or are immune as a result of having been a sufferer previously and 
having now recovered.  The effective basic reproduction number will therefore be 
 
0 sR R p    (A.4) 
 
where sp  is the probability of the person contacted by the infectious person being 
susceptible to catching the disease.  Noting that many contacts in the real world are 








   (A.5) 
 
where the number of susceptible people, sn , is given by: 
 
s rn N n n     (A.6) 
 
Here rn  is the number of people who have been infected and have now recovered, or, in a 
small number of cases, died. 
 
By assumption, the infected people of the current generation will cease to be infectious 
immediately after the point when they have the chance to transfer their infection onto 
others (which will not always happen, as we have seen, due to the growing shortage of 
susceptible people).  This will lead to an increase, rn , in the number of previously 
infectious people.  At the instant of possible transfer, this will be the number in the group, 
Gn :  
 
r Gn n    (A.7) 
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   (A.8) 
 





   (A.9) 
 
Solving this differential equation from  0 0rn   will give the number of people who 
were infectious in the past. 
 
There will be an increase, 1n , in the number of people infected immediately following 
the infection event, which may be found by multiplying by the basic reproduction 
number, R  : 
 
1 Gn Rn    (A.10) 
 









   (A.11) 
 







   (A.12) 
 
The net rate of change in the number of infectious people will be the increase in the 
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   
 
  (A.14) 
 
It may be observed immediately from equation (A.14) that the number of infected people 






   (A.15) 
 
Equivalently, the fraction of the population to have contracted the corona virus will be 








    (A.16) 
 
This is the fraction needed to give herd immunity.  Any new infection introduced to a 
population with herd immunity will be unable to sustain itself and will die away.  This 
does not mean that there will be no transmission, but it means that there will be fewer in 
each succeeding generation of infections.  For an established epidemic, conditions (A.15) 
and (A.16) characterise the peak, when the number of people suffering from the disease is 
a maximum.  The number will then decrease over time to zero (although susceptible 
people will be infected, in declining numbers, on the way down). 
 
Appendix B.  Calculating the final number of deaths in each age group 
 
The cumulative total of infections, Totn , after there are no new infections will be the sum: 
 
     Tot end r end rn n t n t n       (B.1) 
 
where endt  is the time when the epidemic can be declared over. 
 
It is assumed that a third of the infections occur in the household, a third in schools and 
places of work and a third in the community.
19
  Two further assumption are made: first, it 
is assumed that a school child will be twice as likely to become infected as a person 
working and secondly, it is assumed that the infection of people over the age of 85 will 
occur predominantly in the home. 
 
The cumulative number of infections, , ,Tot a gn , at age, a, and gender, g, for infants aged 0 
to 4 and older people aged 67 to 84 will come from two sources, the home and in the 
community, where they will bear their share at each age and gender up to age 84.  Hence 
for these age groups: 
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   (B.2) 
 
where 
,a gp  is the fraction of people of age, a,  and gender, g, in the country (calculated 
from life tables). 
 

















 . Each school child will get two shares in the number of infections to 
one share for each of the people working, which implies that the number of shares in the 
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  .  Hence those aged 5 to 18 will receive a 




2 2a g a g a g






   .  Those aged 
19 to 66 will receive the complementary fraction. 
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   
(B.4) 
 
Those aged 85 or above will face only home infections, and so: 
 
, , ,      for 85 100
3
Tot
Tot a g a g
n
n p a      (B.5) 
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The cumulative fatalities at each age and for each gender, , ,f g an , may then be calculated 
as: 
 
, , , ,f a g a Tot a gn f n   (B.6) 
 
where af , a = 1, 2, ..., 100, is the age-specific fatality rate (Table 1 or Table 2). 
 









    (B.7) 
 
where 
,a gX  is the life expectancy at age, a, and gender, g. 
 










   (B.8) 
 
The life expectancy lost by the average victim who dies is then 
y fn n .  
 
Appendix C.  Using the J-value to find the value of a life year 
 
The up-front equivalent, V , of the annual payments, G , may be calculated by 













     (C.1) 
 
Under strong intergenerational equity, the population-average life expectancy is set to the 
average life expectancy, 1X , of those alive at the installation of the protective measure.  
This implies that the charge, G , will be borne each year by those living at the time of 
installation, but all succeeding cohorts will be spared any part of the financial burden. 
 
Combining equation (6) from the main text with equation (C.1) and putting 1X X  
gives: 
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  (C.2) 
 

















  (C.3) 
 
where the bracketed superscript in 
 1
V  emphasises that this is for a single citizen. 
 
The value of risk-aversion for developed countries is found
10
 to be 0.91  . The social 
discount rate, *r , should be taken as the rate of growth of GDP per head
10
, found to be  
2.03% per annum for the UK for the period 1961 to 2013.
30
  The UK GDP per head
31
 in 
2019 is G = £33,141.  From the latest ONS life tables (for 2016 – 2018), the population-





                                                 
30 World Bank, 2017, "World Development Indicators: GDP per capita growth (annual %)", updated 1 
February. Available at: http://data.worldbank.org/indicator/NY.GDP.PCAP.KD.ZG . 
31 Office of National Statistics, 2020, Gross domestic product (Average) per head, at current market prices: 
SA, https://www.ons.gov.uk/economy/grossdomesticproductgdp/timeseries/ihxt/pn2   
32 Office of National Statistics, 2020, National life tables, UK: 2016 to 2018, 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulleti
ns/nationallifetablesunitedkingdom/2016to2018  
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Age group (years) Age-specific 
fatality rate  
0 – 9 0.002% 
10 – 19 0.006% 
20 – 29  0.03% 
30 – 39 0.08% 
40 – 49  0.15% 
50 – 59 0.60% 
60 – 69  2.2% 
70 – 79  5.1% 
80+ 9.3% 
 
Table 1.  Estimated age-specific fatality rates for the UK 
 
 
Age group (years) Age-specific 
fatality rate  
0 – 9 0% 
10 – 19 0.2% 
20 – 29  0.2% 
30 – 39 0.2% 
40 – 49  0.4% 
50 – 59 1.3% 
60 – 69  3.6% 
70 – 79  8.0% 
80+ 14.8% 
 
Table 2.  Reported age-specific fatality rates for Wuhan 
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 Loss of life  
(years) 
Loss of life  
(plex-2020) 
World War I ~44,000,000 ~1,050,000 
World War II ~22,000,000 ~525,000 
 













loss of life 
(years) 
Residual 






Option 0 (no 
countermeasures) 0 0 0 16,688,465 397,344 Sep 2020 
Option 1 1,395 5,618,411 133,772 11,070,054 263,572 Sep 2020 
Option 2 19 76,493 1,821 16,611,972 395,523 Sep 2021 
Option 3 2,817 11,317,153 269,456 5,371,312 127,888 Sep 2021 
Option 4 4,095 16,499,887 392,854 188,578 4,490 Sep 2021 
 
Table 4.  Comparison of the options against Covid-19
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Figure 1.  Comparison of this paper's model predictions with cumulative recorded 
cases 
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Figure 2.  Number of patients suffering from Covid-19 at a given date.  Option 0. 
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Figure 3.  Number of patients suffering from Covid-19 at a given date. Option 1 
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Figure 4.  Number of patients suffering from Covid-19 at a given date.  Option 2.   
The numbers remain low through the period of restriction, but then the epidemic takes off 
about 2 months later 
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Figure 5.  Number of patients suffering from Covid-19 at a given date.  Option 3. 
(The figure is essentially a delayed version of Figure 2.)
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Figure 6.  Number of patients suffering from Covid-19 at a given date. Option 4 
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Figure 7.  GDP per head in International Dollars (Purchasing Parity Preserved) 
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Figure 8.  Life expectancy at age 42.  Source: Office for National Statistics 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeex
pectancies/datasets/expectationoflifeprincipalprojectionunitedkingdom 
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Figure 9.  Schematic of the transmission of infection 
A contact event with a group of susceptible people will lead to 0R  new infections, but no 
new infections will arise from a contact event with a group of people who are already 
infected or are immune.  The total number of infected people in the next generation will 
be:  0 0 0 00 ... 0 ...Gnext G G G G s Gn R n R n R n M R n n N Rn          where R is the 
currently effective reproduction number, equal to the original number, 0R , multiplied by 
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